Literature DB >> 1968518

The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers.

B M Psaty1, T D Koepsell, E H Wagner, J P LoGerfo, T S Inui.   

Abstract

We conducted a population-based, case-control study of risk factors for first events of coronary heart disease in patients with high blood pressure. All subjects had hypertension treated with medication. The 248 cases presented with new coronary heart disease from 1982 through 1984, and the 737 controls were a probability sample of health maintenance organization patients free of coronary heart disease. The health maintenance organization's computerized pharmacy database identified recent stoppers--patients who did not fill their prescriptions regularly enough to be at least 80% compliant. After adjustment for potential confounding factors, subjects who had recently stopped using beta-blockers had a transient fourfold increase in the relative risk of coronary heart disease (relative risk, 4.5; 95% confidence interval, 1.1 to 18.5). The association was specific to beta-blockers but not diuretics. A withdrawal syndrome immediately following the cessation of beta-blocker use may be an acute precipitant of angina and myocardial infarction in hypertensive patients who have no prior history of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968518

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  57 in total

Review 1.  Accounting for noncompliance in pharmacoeconomic evaluations.

Authors:  D A Hughes; A Bagust; A Haycox; T Walley
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Effect of partial compliance on cardiovascular medication effectiveness.

Authors:  Joyce A Cramer
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

3.  The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response.

Authors:  John Urquhart
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

4.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

Review 5.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

6.  Understanding Adherence and Prescription Patterns Using Large-Scale Claims Data.

Authors:  Margrét V Bjarnadóttir; Sana Malik; Eberechukwu Onukwugha; Tanisha Gooden; Catherine Plaisant
Journal:  Pharmacoeconomics       Date:  2016-02       Impact factor: 4.981

7.  Pharmacological considerations for conscious sedation: clinical applications of receptor function.

Authors:  D E Becker
Journal:  Anesth Prog       Date:  1991 Mar-Apr

8.  Perceived information needs and non-adherence: evidence from Greek patients with hypertension.

Authors:  Charitini Stavropoulou
Journal:  Health Expect       Date:  2011-04-18       Impact factor: 3.377

9.  A cross-national study of the persistence of antihypertensive medication use in the elderly.

Authors:  Boris L G van Wijk; William H Shrank; Olaf H Klungel; Sebastian Schneeweiss; M Alan Brookhart; Jerry Avorn
Journal:  J Hypertens       Date:  2008-01       Impact factor: 4.844

Review 10.  Perioperative hypertensive emergencies.

Authors:  Solomon Aronson
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.